Target intelligence / Profile preview

Serine/threonine-protein kinase Chk2 (CHEK2)

Target
CHEK2
Molecular classification
Kinase, Serine/threonine kinase, Tumor suppressor
01

Overview

Serine/threonine-protein kinase Chk2 (CHEK2) is a multifunctional enzyme and a key component of the DNA damage response (DDR). It acts as a tumor suppressor and plays central roles in cell cycle checkpoint control, DNA repair, apoptosis, and maintenance of genomic stability. CHEK2 is activated primarily in response to DNA double-strand breaks and subsequently phosphorylates various downstream targets involved in cell cycle regulation, DNA repair, and apoptosis. Mutations in CHEK2 are associated with increased cancer susceptibility, making it an attractive target for cancer therapy research.

Other names
Checkpoint kinase 2hCds1RAD53CDS1 homologCHK2 kinase
02

Mechanism of action

CHK2 inhibitors (in development) aim to disrupt its kinase activity, leading to cell cycle arrest or apoptosis in cancer cells with compromised DNA damage response.

03

Biological functions

Cell cycle checkpoint controlDNA damage responseDNA repairApoptosisMaintenance of genomic stabilityMitotic spindle assemblyRegulation of autophagy
04

Disease associations

CancerHereditary breast cancerLi-Fraumeni syndrome
05

Safety considerations

Potential for off-target effects due to kinase family similarityToxicity associated with disrupting DNA damage response in normal cellsDevelopment of resistance mechanisms in cancer cells
06

Biomarkers

CHEK2 mutationsCHK2 expression levelsPhosphorylation status of CHK2 substrates (e.g., p53 Ser20)

Beyond the preview

Go deeper on Serine/threonine-protein kinase Chk2 (CHEK2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serine/threonine-protein kinase Chk2 (CHEK2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call